Publications by authors named "F S Venuti"
Retraction notice to "Trehalose: A biophysics approach to modulate the inflammatory response during endotoxic shock" [Europ. J. Pharmacol. 589 (2008) 272-280].
Eur J Pharmacol
January 2025
Purpose: Non-tuberculous mycobacteria (NTM) account for high clinical burden, and treatment can be challenging. Moreover, accessibility of NTM medications varies across centers. These challenges may lead to unplanned therapeutic changes, discontinuations, potentially affecting patient outcomes.
View Article and Find Full Text PDFArticle Synopsis
- Prolonged SARS-CoV-2 infections are common in immunosuppressed patients, and current treatment options are limited, prompting a study on effective strategies.
- The study involved 15 immunosuppressed patients treated between March 2022 and February 2023, using various combinations of antivirals and monoclonal antibodies, aiming for complete virological response.
- Results showed that 93% of patients tested negative for SARS-CoV-2 within 16 days post-treatment, demonstrating that both sequential and combination therapies can be effective and safe for this high-risk group.
Aim: Higher number of monocytes and neutrophils may correlate with active tuberculosis (TB) in children. However, the few paediatric studies available are limited by the small numbers of children with TB disease or infection included.
Methods: We calculated the monocyte-to-lymphocyte-ratio (MLR), neutrophil-to-lymphocyte-ratio (NLR) and neutrophil-to-monocyte-plus-lymphocyte-ratio (NMLR) in children with active TB, latent TB infection (LTBI), other infectious and non-infectious conditions and healthy children evaluated in two referral centres in Rome.